Manulife Financial Corporation MFC is set to gain from the strength of its Asia business, its expanding Wealth and Asset Management business and a solid capital position. These, along with solid growth projections, make the stock worth retaining. This Zacks Rank #3 (Hold) life insurer has a decent history of delivering surprises for the last six quarters. It has a VGM Score of B. An Outperformer Shares have rallied 20.4% year to date, outperforming the industry’s increase of 9%, the Finance sector’s increase of 5.2% and the S&P 500 composite’s rise of 15%. Optimistic Growth Projection The Zacks Consensus Estimate for 2024 and 2025 earnings per share (EPS) is pegged at $2.74 and $2.96, respectively, suggesting an increase of 6.6% and 8% year over year. The long-term earnings growth rate is currently pegged at 10%. Manulife expects core EPS growth of 10-12% over the medium term. Return on Equity Manulife’s return on equity (ROE) for the trailing 12 months is 16.3%, better than the industry average of 15.5%. This reflects Manulife’s efficiency in utilizing shareholders’ funds. It expects to generate a ROE of 18% by 2027, up from 15% expected earlier. Northbound Estimate Revision The Zacks Consensus Estimate for MFC’s 2024 and 2025 earnings has moved 4 cents and 3 cents north, respectively, in the past 60 days, reflecting analyst optimism. Growth Drivers Manulife is continuously growing its Asia business and now expects core earnings from Asia to contribute 50% to earnings by 2027. Asia has been the fastest-growing insurance segment, supported by strong volume growth and attractive margins. This market appears attractive, given its changing demographics. The life insurer is also investing in high ROE and growth segments in North America to achieve strategic priorities. Manulife’s highest potential businesses, including operations in Asia, Global WAM, Canada group benefits and behavioral insurance products, currently contribute two-thirds to core earnings. The insurer now looks to increase it to 75% and thus is expediting growth in these highest potential businesses. Manulife Asset Management has identified Europe (and the wider EMEA market) as a significant growth area and is making long-term investments in the region In tandem with the wave of accelerated digitalization in the insurance industry, MFC too is digitalizing and automating workflows through GenAI and advanced analytics. Manulife targets an expense efficiency ratio of less than 45% in the medium term. Manulife has been strengthening its balance sheet by improving liquidity and leverage. It targets a leverage ratio of 25%. Notably, its free cash flow conversion has remained more than 100% over the last many quarters, reflecting its solid earnings. Wealth Distribution The life insurer, banking on consistent cash flow, hiked dividends at a six-year CAGR of 10% and targets a 35-45% dividend payout over the medium term. Risks Despite the upside potential, there are a few factors that investors should keep an eye on. Manulife draws a substantial portion of its earnings from the international market, which makes its profitability vulnerable to foreign exchange losses. In an attempt to lower its forex exposure, the company has started incurring hedging costs. Manulife has been forced to raise its reserves to guarantee future liabilities. We anticipate higher reserve charges for its equity-linked products, which will also hurt its earnings. Stocks to Consider Some top-ranked stocks from the insurance space are Reinsurance Group of America RGA, Palomar Holdings PLMR and ProAssurance PRA. Each stock presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. Reinsurance Group delivered a four-quarter average earnings surprise of 19.48%. The stock has gained 26.9% year to date. The Zacks Consensus Estimate for RGA’s 2024 and 2025 earnings implies a 3.9% and 4.3% year-over-year increase, respectively. Palomar’s earnings surpassed estimates in each of the last four quarters, the average earnings surprise being 15.10%. In the past year, PLMR’s stock has surged 40.9%. The Zacks Consensus Estimate for PLMR’s 2024 and 2025 earnings indicates 26% and 18% year-over-year growth, respectively. ProAssurance earnings surpassed estimates in two of the last four quarters and missed in the other two. In the past year, PRA’s stock has lost 10.4%. The Zacks Consensus Estimate for PRA’s 2024 and 2025 earnings implies 371.4% and 72.6% year-over-year growth, respectively. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ProAssurance Corporation (PRA):Free Stock Analysis Report Manulife Financial Corp (MFC):Free Stock Analysis Report Reinsurance Group of America, Incorporated (RGA):Free Stock Analysis Report Palomar Holdings, Inc. (PLMR):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Here's Why Should You Stay Invested in Manulife (MFC) Stock
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...